Adar Poonawalla reacts to allegations of blood clots due to Covishield vaccine

Serum Institute of India CEO Adar Poonawalla cleared the air around Covishield vaccine efficacy and safety as many people in India are still hesitant to take the vaccine. In an interview with India Today, Poonawalla said that Covishield was absolutely safe and gave 94 percent efficacy. The Oxford-AstraZeneca vaccine produced by Serum Institute in Pune has come under a cloud of suspicion after cases of blood clots were reported in some recipients. Watch the video for more details.
----------------------
About the Channel: Watch Business Today videos to get the latest news on Business, stock market, sensex - BSE India, NSE India, personal finance, gold prices, petrol prices and more. Also, get an insight into the dealings of the top companies in India from Business Today's award-winning journalists. Get up to date with all investment options (Mutual Funds, SIPs, Debt, Equity, Insurance, Home Loans, Pension Schemes, Retirement Plans) from our Money Today team. Also, watch interviews of top CEOs.
Regular shows to watch out:

The Good The Bad and The Ugly with BusinessToday.in Editor Rajeev Dubey to know the top stories of the day specially curated from the world of business and economy.

Watch Inside India's Factories to find out how different products get manufactured and processed for final consumption.

You can follow us at:

Website: https://www.businesstoday.in
Facebook: https://www.facebook.com/BusinessToday
Twitter: https://twitter.com/BT_India
Google Plus: https://plus.google.com/+businesstoday

Видео Adar Poonawalla reacts to allegations of blood clots due to Covishield vaccine канала Business Today